The company says it received FDA 510(k) clearance for its OLO analyzer, a device that performs blood tests and provides lab-grade results in minutes.

Detecting early- stage Alzheimer's disease may be as easy as a simple blood test, a new study at Tel Aviv University suggests. The scientists found that the test may be up to 90 percent accurate in predicting the disease.